PEDIATRICS Vol. 65 No. 3 March 1980, pp. 673-674
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Faraj, B. A.
Right arrow Articles by Newman, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Faraj, B. A.
Right arrow Articles by Newman, S. L.

Letters to the Editor

Bahjat A. Faraj PhD1 and Stephen L. Newman MD2

1 Department of Radiology, Emory University School of Medicine, Atlanta, GA 30322
2 Department of Pediatrics, Wright State University School of Medicine, Dayton, OH 45404

We read with great interest the letter by Mitchell and Arcinue concerning our finding of hypertyraminemia in Reye's syndrome patients. Since the acceptance of our manuscript we have confirmed this finding in an additional 16 patients with biopsy-proven Reye's syndrome. The discovery of depressed hepatic monoamine oxidase activity described by the authors confirms our preliminary findings in four patients whose hepatic monoamine oxidase levels were measured in our laboratories. We feel that the work of Mitchell and Arcinue supports our hypothesis that derangement in biogenic amine metabolism may contribute to the encephalopathy of Reye's syndrome.